Shaping the Future of Global Pharmaceutical Regulation
🔬 Navigate Regulations. Accelerate Innovation. Enable Global Access.
The pharmaceutical industry is evolving rapidly—and successful drug development requires more than scientific innovation. Strong regulatory strategies, global policy awareness, and compliance expertise are essential for bringing safe and effective medicines to patients worldwide.
✨ Key Areas of Focus:
🔹 Global Regulatory Pathways – US, EU, UK, Japan, China & Emerging Markets
🔹 Regulatory Strategy & Intelligence
🔹 eCTD 4.0 & Regulatory Writing
🔹 ICH Q8–Q12 & Quality by Design
🔹 GMP, GCP & GLP Harmonization
🔹 Pediatric & Orphan Drug Regulations
🔹 ATMP, RNA & Combination Product Regulations
🔹 Pharmacovigilance & Global Labeling
🚀 Why Join This Track?
✔️ Understand evolving global regulatory pathways
✔️ Strengthen strategic submission planning
✔️ Explore regulatory intelligence and digital tools
✔️ Learn approaches to inspection readiness
✔️ Understand international policy harmonization
✔️ Discover strategies for faster and more efficient global market access
🌐 Event: World Pharmaceutical Sciences & Translational Congress Conference
📍 Location: Rome, Italy and Online
📆 Date: June 17–19, 2027
🎤 Format: In-person and online participation options
👥 Who Should Attend: Researchers, regulatory professionals, pharmaceutical scientists, quality experts, clinical specialists, healthcare professionals, industry leaders, and academic experts
🌐 Connect • Learn • Collaborate • Innovate
Join researchers, regulatory professionals, pharmaceutical scientists, quality experts, clinical professionals, and industry leaders to explore the future of global pharmaceutical regulation and policy.
📢 Share Your Research & Be Part of the Discussion!
📄 Submit Your Abstract
Share your research, case study, or professional insights with an international audience:
https://pharmaceuticalsciencesconference.com/abstract-submission
#PharmaceuticalSciences #RegulatoryAffairs #GlobalPolicy #PharmaceuticalRegulation #RegulatoryIntelligence #DrugDevelopment #PharmaIndustry #ICH #eCTD #GMP #GCP #GLP #Pharmacovigilance #DrugSafety #MarketAccess #PharmaInnovation #HealthcareInnovation
No comments:
Post a Comment